|
- The leading innovative plug-and-play ultrasonic shears with integrated transducer designed for open surgery
SINGAPORE, June 3, 2026 /PRNewswire/ -- Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for SOUND REACHTM Swift, ultrasonic shears designed for open surgical procedures, including breast and thyroid surgeries.
SOUND REACH Swift features a plug-and-play, single-unit innovative design that integrates a customised, lightweight power transducer with a fine curved-tip blade, enabling efficient and consistent ultrasonic energy delivery. This supports reliable coagulation for vessels up to 5 mm and precise dissection in confined anatomy, while simplifying preoperative preparation by eliminating conventional handpiece assembly and separate handpiece management and sterilisation.
Featuring a forceps-style design based on instruments commonly used in open surgery, SOUND REACH Swift enables tissue grasping, dissection and coagulation within a single device, reducing the need for instrument exchanges. Its compact, lightweight design improves hand manoeuvrability and helps reduce surgeon fatigue during prolonged procedures.
Together, these features support ease of use and workflow efficiency during open surgery, particularly in thyroid and breast surgeries performed within confined anatomical spaces and near critical structures. In these settings, controlled energy delivery and effective thermal management are essential. SOUND REACH Swift has been designed to meet these procedural requirements and challenges.
In thyroid and breast surgeries, demand continues to grow with rising global disease burden. GLOBOCAN 2022 estimates 2.3 million new breast cancer cases and approximately 821,000 thyroid cancer cases globally. This rising trend drives greater focus on technologies that support tissue protection, reduce procedural complexity, and deliver consistent performance in the operating theatre.
SOUND REACH Swift expands Reach Surgical's energy portfolio into open surgery, complementing its ultrasonic and advanced bipolar technologies available on the ENER REACH OP9 platform, which supports both energy modalities within a single system.
Regulatory Notice: SOUND REACHTM Swift is a registered trademark of Reach Surgical. Product availability is subject to local regulatory approvals.
About Genesis MedTech Group
Genesis MedTech Group is a global medical device company headquartered in Singapore, dedicated to Making Better Healthcare Happen. We design and develop medical technologies that make treatments less invasive and more accessible at scale, supporting healthcare providers in delivering quality care and enabling more patients to benefit from medical advances. With integrated capabilities from R&D and manufacturing to commercialisation, Genesis MedTech builds on a strong foundation of quality, training and education, serving surgical, cardiology, and vascular interventional specialties.
Reach Surgical, the surgical solutions division of Genesis MedTech, provides a comprehensive surgical portfolio designed to support surgeons and advance surgical care. Through product development, clinical education and collaboration with surgeons, Reach Surgical is committed to addressing the evolving needs of modern surgery.
Learn more at https://www.genesismedtech.com and follow us on LinkedIn.
- The leading innovative plug-and-play ultrasonic shears with integrated transducer designed for open surgery
SINGAPORE, June 3, 2026 /PRNewswire/ -- Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for SOUND REACHTM Swift, ultrasonic shears designed for open surgical procedures, including breast and thyroid surgeries.
SOUND REACH Swift features a plug-and-play, single-unit innovative design that integrates a customised, lightweight power transducer with a fine curved-tip blade, enabling efficient and consistent ultrasonic energy delivery. This supports reliable coagulation for vessels up to 5 mm and precise dissection in confined anatomy, while simplifying preoperative preparation by eliminating conventional handpiece assembly and separate handpiece management and sterilisation.
Featuring a forceps-style design based on instruments commonly used in open surgery, SOUND REACH Swift enables tissue grasping, dissection and coagulation within a single device, reducing the need for instrument exchanges. Its compact, lightweight design improves hand manoeuvrability and helps reduce surgeon fatigue during prolonged procedures.
Together, these features support ease of use and workflow efficiency during open surgery, particularly in thyroid and breast surgeries performed within confined anatomical spaces and near critical structures. In these settings, controlled energy delivery and effective thermal management are essential. SOUND REACH Swift has been designed to meet these procedural requirements and challenges.
In thyroid and breast surgeries, demand continues to grow with rising global disease burden. GLOBOCAN 2022 estimates 2.3 million new breast cancer cases and approximately 821,000 thyroid cancer cases globally. This rising trend drives greater focus on technologies that support tissue protection, reduce procedural complexity, and deliver consistent performance in the operating theatre.
SOUND REACH Swift expands Reach Surgical's energy portfolio into open surgery, complementing its ultrasonic and advanced bipolar technologies available on the ENER REACH OP9 platform, which supports both energy modalities within a single system.
Regulatory Notice: SOUND REACHTM Swift is a registered trademark of Reach Surgical. Product availability is subject to local regulatory approvals.
About Genesis MedTech Group
Genesis MedTech Group is a global medical device company headquartered in Singapore, dedicated to Making Better Healthcare Happen. We design and develop medical technologies that make treatments less invasive and more accessible at scale, supporting healthcare providers in delivering quality care and enabling more patients to benefit from medical advances. With integrated capabilities from R&D and manufacturing to commercialisation, Genesis MedTech builds on a strong foundation of quality, training and education, serving surgical, cardiology, and vascular interventional specialties.
Reach Surgical, the surgical solutions division of Genesis MedTech, provides a comprehensive surgical portfolio designed to support surgeons and advance surgical care. Through product development, clinical education and collaboration with surgeons, Reach Surgical is committed to addressing the evolving needs of modern surgery.
Learn more at https://www.genesismedtech.com and follow us on LinkedIn.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Reach Surgical Receives CE Mark Approval for SOUND REACH™ Swift
|
GRENOBLE, France, June 3, 2026 /PRNewswire/ -- Quobly, a French quantum computing company, today announced the closing of a €115 million Series A financing to accelerate the industrialization of its silicon-based quantum computers and bring its first commercial product to market by the end of 2026.
- The round is led by Bpifrance, SEALSQ and STMicroelectronics, with participation from the European Innovation Council (EIC Fund), Blast, ALIAD (Air Liquide Venture Capital) and existing investor Innovacom, bringing together leading industrial, sovereign and deeptech investors. Existing shareholders also include the CEA, CNRS, Quantonation and Supernova Invest.
Long-time investor Bpifrance is participating through the Deep Tech 2030 fund, managed on behalf of the French government as part of the France 2030 initiative. - This financing will support continued R&D, industrialization efforts and international commercial expansion.
- Quobly, bringing semiconductor-grade manufacturing and industrialization to quantum computing, plans to deploy its first commercial quantum computer through the cloud by the end of 2026 under its Alloy product line.
From technology validation to commercial deployment at scale
This Series A marks a key step in Quobly's roadmap to industrial-scale quantum computing, transitioning from early validation to the production of its first commercial systems.
Alloy Pioneer, the first computer in Quobly's Alloy product line, is designed for early adopters in high-performance computing and research environments. The system will be accessible through the cloud in 2026, before deployment within HPC infrastructures in 2027.
Quobly's quantum computers are designed to integrate into existing HPC and data-center infrastructures, with a compatible footprint, power supply and utility requirements, enabling straightforward deployment.
Alloy Pioneer is accessible through Alloy Forge, Quobly's quantum application development environment, enabling users to develop and validate applications under realistic hardware constraints.
The company will in particular:
- Increase the performance and scalability of its quantum computer product line,
- Accelerate the industrialization and scaling of its silicon quantum processors,
- Deploy its first Alloy systems into customer cloud and HPC environments.
These efforts will be supported by the continued expansion of Quobly's hardware, control electronics and software stack, in line with its system-level co-design approach.
This Series A follows Quobly's €19 million seed phase (2023-2025), during which the company demonstrated the feasibility of developing silicon qubits within semiconductor manufacturing processes, and established a system-level architecture integrating device, control and software layers.
Scaling quantum computing through semiconductor manufacturing
Quobly's approach is based on the use of FD-SOI technology on 300 mm wafers, leveraging established semiconductor manufacturing processes to address key challenges in scalability, yield and reproducibility. The company develops silicon qubits designed for dense integration and compatibility with industrial fabrication standards.
As part of this strategy, Quobly leverages semiconductor-grade capabilities across the broader semiconductor ecosystem through strategic partnerships with industrial leaders including STMicroelectronics, Air Liquide, Soitec and Orano. These collaborations accelerate the transfer of Quobly's quantum technologies into advanced manufacturing environments and support the industrial integration of process control, materials engineering, cryogenics and yield optimization from the earliest stages of deployment.
This industrial-first approach sets Quobly apart by prioritizing manufacturability and technology-system co-development.
Executive commentary
Maud Vinet, CEO and co-founder, Quobly
"This financing marks a transition from technology validation to industrial execution. Over the past two years, we have demonstrated that silicon qubits can be developed within semiconductor manufacturing processes and integrated into a system architecture. With this Series A, we are accelerating the deployment of our first commercial systems and building a quantum computing platform designed to integrate into existing computing infrastructures. Our objective is to make quantum computing deployable, scalable and usable within real industrial environments."
Investor perspectives
Laurent Malier, Executive Vice President, Global Technology R&D, STMicroelectronics
"Quantum computing will achieve the scale needed by HPC customers only if breakthrough quantum systems can be industrialized and integrated with semiconductor-grade rigor and backed by a robust ecosystem. We are leveraging years of shared expertise in FD-SOI and deep technological collaboration to accelerate the commercialization of Quobly's products thanks to a 300mm silicon fab environment. ST's investment in Quobly further demonstrates our commitment to support its global ambitions."
Gwenaël Hamon, Senior Investment Director, Bpifrance
"Our second investment in Quobly is fully in line with our ambition to support the emergence of sovereign technology champions. By choosing a quantum architecture compatible with established microelectronics industry standards, Quobly paves the way for the rapid and controlled industrialization of breakthrough technologies, an essential condition to ensure Europe's strategic autonomy in quantum computing."
Carlos Moreira, CEO, SEALSQ
"SEALSQ is proud to participate as a lead investor in Quobly's Series A financing. This investment builds on the technical partnership initiated in 2025. By combining Quobly's silicon-based quantum processors with SEALSQ's post-quantum security technologies, this collaboration contributes to the development of secure quantum computing systems. It supports the development of trusted quantum systems for industrial and critical applications."
Philippe Delmas, Chairman of the Board, Quobly
"Quobly represents a rare combination of breakthrough scientific capability and industrial execution discipline. The company is positioning itself at the intersection of quantum computing, semiconductor manufacturing and high-performance computing infrastructure, three strategic domains that will shape the next generation of computing technologies."
Advisors
Financial advisors to Quobly were Avolta and Rochefort & Associés. Legal advisors to Quobly were Goodwin and Kelten.
Legal advisors to investors included Bignon Lebray, Jones Day and Rimon Law. Financial advisory support was provided by Forvis Mazars.
Bank financing partners included BNP Paribas, Bpifrance, Caisse d'Epargne Rhône-Alpes and Société Générale.
About Quobly
Visit our website and follow us on LinkedIn.
Contact media: marie.cabrieres@quobly.io
GRENOBLE, France, June 3, 2026 /PRNewswire/ -- Quobly, a French quantum computing company, today announced the closing of a €115 million Series A financing to accelerate the industrialization of its silicon-based quantum computers and bring its first commercial product to market by the end of 2026.
- The round is led by Bpifrance, SEALSQ and STMicroelectronics, with participation from the European Innovation Council (EIC Fund), Blast, ALIAD (Air Liquide Venture Capital) and existing investor Innovacom, bringing together leading industrial, sovereign and deeptech investors. Existing shareholders also include the CEA, CNRS, Quantonation and Supernova Invest.
Long-time investor Bpifrance is participating through the Deep Tech 2030 fund, managed on behalf of the French government as part of the France 2030 initiative. - This financing will support continued R&D, industrialization efforts and international commercial expansion.
- Quobly, bringing semiconductor-grade manufacturing and industrialization to quantum computing, plans to deploy its first commercial quantum computer through the cloud by the end of 2026 under its Alloy product line.
From technology validation to commercial deployment at scale
This Series A marks a key step in Quobly's roadmap to industrial-scale quantum computing, transitioning from early validation to the production of its first commercial systems.
Alloy Pioneer, the first computer in Quobly's Alloy product line, is designed for early adopters in high-performance computing and research environments. The system will be accessible through the cloud in 2026, before deployment within HPC infrastructures in 2027.
Quobly's quantum computers are designed to integrate into existing HPC and data-center infrastructures, with a compatible footprint, power supply and utility requirements, enabling straightforward deployment.
Alloy Pioneer is accessible through Alloy Forge, Quobly's quantum application development environment, enabling users to develop and validate applications under realistic hardware constraints.
The company will in particular:
- Increase the performance and scalability of its quantum computer product line,
- Accelerate the industrialization and scaling of its silicon quantum processors,
- Deploy its first Alloy systems into customer cloud and HPC environments.
These efforts will be supported by the continued expansion of Quobly's hardware, control electronics and software stack, in line with its system-level co-design approach.
This Series A follows Quobly's €19 million seed phase (2023-2025), during which the company demonstrated the feasibility of developing silicon qubits within semiconductor manufacturing processes, and established a system-level architecture integrating device, control and software layers.
Scaling quantum computing through semiconductor manufacturing
Quobly's approach is based on the use of FD-SOI technology on 300 mm wafers, leveraging established semiconductor manufacturing processes to address key challenges in scalability, yield and reproducibility. The company develops silicon qubits designed for dense integration and compatibility with industrial fabrication standards.
As part of this strategy, Quobly leverages semiconductor-grade capabilities across the broader semiconductor ecosystem through strategic partnerships with industrial leaders including STMicroelectronics, Air Liquide, Soitec and Orano. These collaborations accelerate the transfer of Quobly's quantum technologies into advanced manufacturing environments and support the industrial integration of process control, materials engineering, cryogenics and yield optimization from the earliest stages of deployment.
This industrial-first approach sets Quobly apart by prioritizing manufacturability and technology-system co-development.
Executive commentary
Maud Vinet, CEO and co-founder, Quobly
"This financing marks a transition from technology validation to industrial execution. Over the past two years, we have demonstrated that silicon qubits can be developed within semiconductor manufacturing processes and integrated into a system architecture. With this Series A, we are accelerating the deployment of our first commercial systems and building a quantum computing platform designed to integrate into existing computing infrastructures. Our objective is to make quantum computing deployable, scalable and usable within real industrial environments."
Investor perspectives
Laurent Malier, Executive Vice President, Global Technology R&D, STMicroelectronics
"Quantum computing will achieve the scale needed by HPC customers only if breakthrough quantum systems can be industrialized and integrated with semiconductor-grade rigor and backed by a robust ecosystem. We are leveraging years of shared expertise in FD-SOI and deep technological collaboration to accelerate the commercialization of Quobly's products thanks to a 300mm silicon fab environment. ST's investment in Quobly further demonstrates our commitment to support its global ambitions."
Gwenaël Hamon, Senior Investment Director, Bpifrance
"Our second investment in Quobly is fully in line with our ambition to support the emergence of sovereign technology champions. By choosing a quantum architecture compatible with established microelectronics industry standards, Quobly paves the way for the rapid and controlled industrialization of breakthrough technologies, an essential condition to ensure Europe's strategic autonomy in quantum computing."
Carlos Moreira, CEO, SEALSQ
"SEALSQ is proud to participate as a lead investor in Quobly's Series A financing. This investment builds on the technical partnership initiated in 2025. By combining Quobly's silicon-based quantum processors with SEALSQ's post-quantum security technologies, this collaboration contributes to the development of secure quantum computing systems. It supports the development of trusted quantum systems for industrial and critical applications."
Philippe Delmas, Chairman of the Board, Quobly
"Quobly represents a rare combination of breakthrough scientific capability and industrial execution discipline. The company is positioning itself at the intersection of quantum computing, semiconductor manufacturing and high-performance computing infrastructure, three strategic domains that will shape the next generation of computing technologies."
Advisors
Financial advisors to Quobly were Avolta and Rochefort & Associés. Legal advisors to Quobly were Goodwin and Kelten.
Legal advisors to investors included Bignon Lebray, Jones Day and Rimon Law. Financial advisory support was provided by Forvis Mazars.
Bank financing partners included BNP Paribas, Bpifrance, Caisse d'Epargne Rhône-Alpes and Société Générale.
About Quobly
Visit our website and follow us on LinkedIn.
Contact media: marie.cabrieres@quobly.io
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Quobly secures €115 million Series A to bring silicon-based quantum computers to market
